Our study found that patients with NAFLD and UCP2 45 bp D/D or D/I genotype had significantly higher TG, ALT, AST, and lower HDL levels than healthy controls. The gene discussed is UCP2; the disease is metabolic dysfunction-associated steatotic liver disease.